You are here: Industry Insights > GSK

News List

Nvidia partners with GSK’s AI lab for drug discovery pharmaceutical-technology
October 10, 2020
US-based chipmaker Nvidia has entered into a partnership with GlaxoSmithKline (GSK) and its artificial intelligence (AI) group for the discovery of drugs and vaccines.
First UK patient given GSK’s experimental arthritis drug in COVID-19 trial pharmatimes
September 30, 2020
A patient in Manchester is the first in the UK to be treated in a new COVID-19 trial investigating the use of an experimental arthritis drug, otilimab, for severe lung disease related to the novel coronavirus.
EU to receive 300 million COVID-19 vaccine doses from Sanofi and GSK europeanpharmaceuticalreview
September 27, 2020
A contract for 300 doses of the investigational COVID-19 vaccine candidate has been signed by the European Commission (EC).
Sanofi and GSK sign Covid-19 vaccine supply deal with Canada pharmaceutical-technology
September 24, 2020
Sanofi and GlaxoSmithKline (GSK) have signed a deal with the Government of Canada to supply up to 72 million doses of adjuvanted Covid-19 vaccine candidate from next year.
GSK’s Zejula and AZ’s Lynparza leap toward broader EU approval pharmatimes
September 23, 2020
GlaxoSmithKline’s Zejula and AstraZeneca’s Lynparza have both moved towards EU approval in new indications after receiving positive opinions from the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP).
Sanofi and GSK agree to supply Covid-19 vaccine doses to EU pharmaceutical-technology
September 22, 2020
Sanofi and GlaxoSmithKline (GSK) have signed an advanced purchase agreement with the European Commission (EC) to supply up to 300 million doses of their potential Covid-19 vaccine, following regulatory approval.
GSK gets US FDA approval for Trelegy Ellipta to treat asthma, COPD expresspharma
September 18, 2020
Trelegy is the first single inhaler triple therapy approved for the maintenance treatment of both asthma and COPD.
GSK establishes AI hub in London to discover new drugs pharmaceutical-technology
September 07, 2020
GlaxoSmithKline (GSK) has opened a £10m research hub in King’s Cross, London, UK, to leverage artificial intelligence (AI) for the discovery of new drugs to treat cancer and other diseases.
Sanofi, GSK initiate Phase 1/2 clinical trial of COVID-19 vaccine candidate expresspharma
September 04, 2020
440 participants are being enrolled in the trial across 11 investigational sites in the US, companies expect first results in early December 2020.
GSK, Vir Biotech to test COVID-19 antibody treatment expresspharma
September 02, 2020
The long-acting single injection will be tested on recently diagnosed high-risk cases for its ability to prevent hospitalisation.

Previous page 1 2 3 4 5 6 7 8 9 10 ... 40 41 Next page